Assessing the Toxoplasma Tachyzoite Cell Cycle Phases Using Fluorescent Ubiquitination-Based Cell Cycle Indicator. [PDF]
Batra M, Suvorova ES.
europepmc +1 more source
Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models. [PDF]
Tamburello M +10 more
europepmc +1 more source
Pro-tumourigenic effects of DCAF13 on the progression of colorectal cancer. [PDF]
Zhang W +7 more
europepmc +1 more source
Cell cycle-related biomarker lineage promotes the malignant progression of recurrent IDH wild-type glioma. [PDF]
Xu J +5 more
europepmc +1 more source
Next Generation DNA Damage Response Inhibitors: Harnessing Nanocarriers and Tumor Microenvironment for Precision Cancer Therapy. [PDF]
Solomon AD +8 more
europepmc +1 more source
Bioinformatics analysis of DLGAP5 as a biomarker in lung adenocarcinoma: implications for immune infiltration and targeted therapy. [PDF]
Jiao L, Xu X, Liu Y, Li F, Li C, Wu T.
europepmc +1 more source
The expression of tyrosine kinase and threonine promotes the progression of lung adenocarcinoma and is linked to a negative prognosis. [PDF]
Zhu X, Li S, Ye L, Ye L.
europepmc +1 more source
Crocin and eugenol enhance radiosensitivity in oral squamous cell carcinoma cells via apoptotic pathways and cell cycle regulation. Type of study: in vitro. [PDF]
Heidari MT +3 more
europepmc +1 more source
C1orf112 promotes breast cancer growth by modulating the cell cycle. [PDF]
Fang Y +8 more
europepmc +1 more source
SKP2 protein as a prognostic biomarker for glioma and promotes tumor progression by regulating the cell cycle. [PDF]
Guan L +5 more
europepmc +1 more source

